ID   DM13/B7-7
AC   CVCL_ZL67
DR   Wikidata; Q98125879
RX   PubMed=7703289;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6621 ! DM13
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
RX   PubMed=7703289; DOI=10.1089/hum.1995.6.1-87;
RA   Fenton R.T., Sznol M., Luster D.G., Taub D.D., Longo D.L.;
RT   "A phase I trial of B7-transfected or parental lethally irradiated
RT   allogeneic melanoma cell lines to induce cell-mediated immunity
RT   against tumor-associated antigen presented by HLA-A2 or HLA-A1 in
RT   patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol
RT   9401.";
RL   Hum. Gene Ther. 6:87-106(1995).
//